Indian court dismisses Teva’s bid to block Copaxone generic

03-03-2014

Indian court dismisses Teva’s bid to block Copaxone generic

Photo: Tevapharm.com

The Delhi High Court has dismissed Teva’s action to stop Hyderabad-based Natco Pharma from marketing a generic version of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate).


Teva, Natco, Copaxone, copolymer-1, Delhi High Court

LSIPR